 |
 |
|
Home | About Natural News | Contact Us | Write for Natural News | Media Information | |||
|
|
|||
|
||||
|
||||
|
||||
 |
|||||||||||||||
FDA Routinely Ignores Financial Conflicts of Interest in Clinical Trials Relied on to Approve DrugsBy Mike Adams, January 13, 2009 | Key concepts: FDA, Conflicts of interest and Clinical trials The FDA claims it sets the "gold standard" of scientific integrity in approving drugs, but in reality, the agency utterly fails to address the issue of financial conflicts of interests in clinical trials, it turns out.That's the conclusion from the Inspector General of the Department of Health and Human Services (HHS). As the NY Times reported, the following disturbing facts have emerged from this HHS investigation: • Out of the 58 percent of clinical trials in which the FDA did receive financial disclosure information, the FDA didn't even look at nearly one-third of the financial disclosure reforms, the inspector general says. (In other words, the FDA is filing the financial disclosure forms in the "round file.") • When doctors and researchers admitted serious conflicts of interest on the disclosure forms, the FDA did absolutely nothing to deal with the conflicts in 20 percent of the cases. • The NYT interviewed an FDA spokesperson who admitted on the record that the FDA does not review doctors' conflicts of interest in drug trials because, they say, the conflicts are not a sufficient source of bias to disqualify those researchers. • The NYT also reports that from 20 to 33 percent of all doctors who oversee clinical trials have financial conflicts of interest. • The FDA believes that collecting and reviewing financial disclosure information from doctors overseeing clinical trials is "not worth the effort" and really has no commitment to the process. The upshot of all this is that the FDA is utterly failing to investigate and act on conflicts of interest in the clinical trials it relies on to approve prescription medications. No wonder so many dangerous, deadly drugs manage to get through the FDA approval process.
Related Feature Articles:
|
Fish oil is old news... GLM is the *new* marine omega-3 powerhouseLearn why so many NaturalNews readers are switching from fish oil to THIS. What is THIS? See the details...Click the link for full details. See the science and the user testimonials.
|
||||||||||||||
Home | About Natural News | Contact Us | Write for Natural News | Media Information | Advertise with Natural News This site is part of the Natural News Network © 2009 All Rights Reserved. Privacy | Terms All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing International, LTD. is not responsible for content written by contributing authors. The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Truth Publishing assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms and those published here. All trademarks, registered trademarks and servicemarks mentioned on this site are the property of their respective owners. |
 |
Subscribe now to receive a summary of each day's most important natural health stories, plus get full, free access to the entire archives of books on HealthBookSummaries. 
